Global orthopedic devices market to grow at a CAGR of 4.57% during the period 2016-2020

About Orthopedic Devices

Orthopedic devices are the instruments and implants used in orthopedic surgeries to replace an injured bone or missing joint and to support a damaged bone. These devices can be made of metal, ceramic, or plastic.

To Download Sample Report With TOC@ http://www.researchmoz.us/enquiry.php?type=S&repid=527286

Analysts forecast the global orthopedic devices market to grow at a CAGR of 4.57% during the period 2016-2020.
Covered in this report
The report covers the present scenario and the growth prospects of the global orthopedic devices market for 2015-2020. To calculate the market size, the report considers the revenue generated from the sales of the following device segments:
Spine
Trauma and extremities
Knee
Hip
Foot and ankle

Report, Global Orthopedic Devices Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors DePuy Synthes
Medtronic
Smith & Nephew
Stryker
Zimmer-Biomet

Other prominent vendors AAP Implantate
Acumed
Aesculap Implant Systems
Arthrex
Arthrosurface
Alphatec Spine
Bonovo Orthopedics
ConforMIS
Corin
Elite Surgical
Ellipse Technologies
EUROS FRANCE
Exactech
FH ORTHOPEDICS
Globus Medical
K2M
Integra LifeSciences
Lima Corporate
Medartis
Medacta
Microport Medical
NuVasive
Ortosintese
Orthopaedic Implant Company
Orthofix International
Osteomed
PETER BREHM
Surgival
Tornier
Tyber Medical
Zavation

Market driver Growing incidence of orthopedic disorders
For a full, detailed list, view our report

Market challenge Post-surgery complications
For a full, detailed list, view our report

Market trend Adoption of robot assistance surgery
For a full, detailed list, view our report

Key questions answered in this report What will the market size be in 2020 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analysts time when you purchase this market report. Details are provided within the report.
More ....

To Enquire Regarding This Report@ http://www.researchmoz.us/enquiry.php?type=E&repid=527286

About ResearchMoz

ResearchMoz is the world’s fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz’s service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.

Blog: http://dynamicmarketresearch.blogspot.com/

Biosimilars (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023

Rheumatoid arthritis (RA) is a chronic autoimmune disease which causes inflammation and deformity of the joints . It affects over seven million individuals in the 10MM covered in this report (US, France, Germany, Italy, Spain, UK, Japan, Australia, China, and India) and the prevalence is expected to grow to just over 8.5 million individuals by 2023. The anti-TNFs have been effective in treating the signs and symptoms of RA and inhibiting progression to erosive bone disease. However, the landscape is quickly changing with the introduction of biosimilars, novel biologics, and a class of oral therapies known as JAK inhibitors, all of which will change the market dynamics between 2013 and 2023. With the anti-TNFs as extremely effective therapies for RA, the market is extremely competitive for new entrants and will undergo further pressure as biosimilars are approved and launch.

To Download Sample Report With TOC@ http://www.researchmoz.us/enquiry.php?type=S&repid=247143

With the cost of biologic therapies being very high, at an annual cost of at least $25,000, global healthcare systems need a reprieve from the expense. On September 9, 2013, Hospiras Inflectra and Celltrions Remsima, which are both biosimilars of J&Js Remicade, were approved by the European Commission (EC) for marketing in the EU for multiple autoimmune diseases, including RA, Crohns disease, ulcerative colitis, ankylosing spondylitis, and psoriatic arthritis. Remsima and Inflectra have been rolled out in selected European markets, although their launch in the 5EU is still pending due to potential intellectual property protections in these healthcare markets. The US-based generics company, Hospira, will market Inflectra in the EU, while the South Korean biotechnology company, Celltrion, the original developer of the infliximab biosimilar, will do so as well, but under the brand name Remsima, based on a collaboration forged between the two companies in 2009.

Scope

Overview of Rheumatoid Arthritis, including epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines as well as an overview on the competitive landscape.
Detailed information on Biosimilars including product description, safety and efficacy profiles as well as a SWOT analysis.
Sales forecast for Biosimilars for the top 10 countries from 2013 to 2023.
Sales information covered for the US, France, Germany, Italy, Spain, the UK and Japan, Australia, China and India.

Reasons to buy

Understand and capitalize by identifying products that are most likely to ensure a robust return.
Stay ahead of the competition by understanding the changing competitive landscape for Rheumatoid Arthritis.
Effectively plan your M&A and partnership strategies by identifying drugs with the most promising sales potential.
Make more informed business decisions from insightful and in-depth analysis of Biosimilars performance.
Obtain sales forecast for Biosimilars from 2013-2023 in top 10 countries (the US, France, Germany, Italy, Spain, the UK and Japan, Australia, China and India).
More ....

To Enquire Regarding This Report@ http://www.researchmoz.us/enquiry.php?type=E&repid=247143

About ResearchMoz
ResearchMoz is the world’s fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz’s service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.

Blog: http://dynamicmarketresearch.blogspot.com/

Fertility services market in the US to grow at a CAGR of 4.07% during the period 2016-2020

About Fertility

Couples with fertility issues are unable to conceive even after regular unprotected coitus (six months if the woman is over age 35). Female or male infertility factors account for one-third of the cases, where a couple is unable to conceive. In the rest of the cases, the cause is either unknown or a combination of both male and female infertility factors.

To Download Sample Report With TOC@ http://www.researchmoz.us/enquiry.php?type=S&repid=560799

In males, low sperm production, abnormal sperm function, or blockages that prevent the delivery of sperm can lead to infertility. In females, hormonal changes, fallopian tube damage, endometriosis, and cervical abnormalities can lead to infertility. Diagnosing the cause of infertility can be difficult but people with fertility issues have many treatment options depending on the underlying problem.

Analysts forecast the fertility services market in the US to grow at a CAGR of 4.07% during the period 2016-2020.

Covered in this reportThe report covers the present scenario and the growth prospects of the fertility treatment market in the US for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of fertility drugs and the use of assisted reproductive technology (ART).

The market is divided into the following segments based on treatment type:ART
Infertility drugs

Technavio's report, Fertility Market in the US 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendorsCellcura
CooperSurgical
Intramed
Ferring Pharmaceuticals
Merck

Other prominent vendorsAbbott Laboratories
AbbVie
Actavis
Apricus Biosciences
AstraZeneca
Auxogyn
Bristol-Myers Squibb
Elelixis Diagnostics
Eli Lilly
EMD Serono
IKS International
In Vitro Care
Invo Bioscience
Irvine Scientific
IVFtech Aps
Life Global
Medical Electronic Systems
Meditex
Novartis
Ovascience
Pantec Biosolutions
Pfizer
Sanofi
Vivus
Xytex Cryo International

Market driverEmergence of ART and acceptance of same-sex marriage
For a full, detailed list, view our report

Market challengeHigh cost of fertility treatment
For a full, detailed list, view our report

Market trendIncrease in M&A
For a full, detailed list, view our report

Key questions answered in this reportWhat will the market size be in 2020 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analysts time when you purchase this market report. Details are provided within the report.
More ....

To Enquire Regarding This Report@ http://www.researchmoz.us/enquiry.php?type=E&repid=560799

About ResearchMoz

ResearchMoz is the world’s fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz’s service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.

Blog: http://dynamicmarketresearch.blogspot.com/

Mobile Healthcare (mHealth) Bible: 2015 - 2020

With more than 7 Billion mobile network subscriptions worldwide, the mobile communications sector is rapidly gaining traction from a diverse range of vertical sectors. Healthcare is no exception to this trend.

As healthcare providers seek to maximize their patient outreach while minimizing costs, many view mobile healthcare (or mHealth) as the solution to improve healthcare cost-efficiency. mHealth refers to the usage of mobile communications technology & devices to enhance access to healthcare information, improve distribution of routine and emergency health services and provide diagnostic services.

To Download Sample Report With TOC@ http://www.researchmoz.us/enquiry.php?type=S&repid=232268

Mobile network operators also view mHealth as a lucrative opportunity for the monetization of their mobile connectivity services. Given that most operators have established themselves as reputable consumer brands, they are also eyeing on opportunities to offer services beyond simple connectivity. Many operators already offer branded or co-branded end-to-end mHealth solutions to their customer bases.

In addition, mHealth offers a multitude to opportunities to the pharmaceutical industry ranging from R&D activities to securing the supply chain and, in the battle against counterfeit drugs.

Driven by the thriving ecosystem, SNS Research estimates that the mHealth market will account for nearly $13 Billion in 2015 alone. Despite barriers relating to regulation, patient acceptance and privacy concerns, SNS Research estimates further growth at a CAGR of nearly 40% over the next 6 years.

This report presents an in-depth assessment of the global mHealth market. In addition to covering key market drivers, challenges, future roadmap, value chain analysis, deployment case studies, service/product strategies and strategic recommendations, the report also presents comprehensive forecasts for the mHealth market from 2014 till 2020. Historical revenue figures for 2010, 2012 and 2013 are also presented. The forecasts and historical revenue figures are individually segmented for 5 individual submarkets, 29 use case categories, 5 ecosystem player categories, 6 geographical regions and 34 countries.

The report comes with an associated Excel datasheet covering quantitative data from all figures presented within the report.
More ....

To Enquire Regarding This Report@ http://www.researchmoz.us/enquiry.php?type=E&repid=232268

About ResearchMoz

ResearchMoz is the world’s fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz’s service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.

Blog: http://dynamicmarketresearch.blogspot.com/

Global In-Vitro Diagnostics (IVD) Market Report: 2014 Edition

An in-vitro diagnostic test is performed outside of a human body in an artificial environment (e.g. laboratory). IVD is considered as an essential part of today’s healthcare. The IVD products are broadly divided into three categories: reagents, analytical instruments and accessory products. IVD is widely used for diagnosis, monitoring of prescribed treatments and assessment of medical intervention, apart from others thereby contributing to availability of medical information regarding a patient. Furthermore, IVD allows earlier and more targeted treatment which in turn leads to reduced hospital stays and convalescences resulting in a healthier population and economic growth in the long run.

To Download Sample Report With TOC@ http://www.researchmoz.us/enquiry.php?type=S&repid=242777

A constant growth has been observed in the global IVD industry since 2009. In IVD by technology, immunoassay and conventional chemistry strongly dominates the market. Laboratory test lead the IVD market by test location followed by self-test. Infectious disease is the largest segment covering the IVD market. On the basis of IVD products, reagent has the maximum market share.

The key factors which are anticipated to drive market growth include rising global healthcare expense, increasing global ageing population, accelerating global diabetic population apart from rising incidences of chronic and infectious diseases and increasing global gross national income. Some of the noteworthy developments of this industry include food safety testing market being taken over, development in patient monitoring and telemedicine, continued expansion of POC testing apart from mergers and acquisitions. However, the industry remains threatened by certain challenges which include lack of economies of scale and scope, increase in investment demands apart from usual regulatory, reimbursement and intellectual property issues.

This report offers a comprehensive analysis of the global in-vitro diagnostic market, along with an in-depth study of the IVD segments and the regional markets of Europe and China. The global IVD industry is consolidated with the top players, Abbott, Siemens, Roche and Johnson and Johnson which operate in a highly competitive environment. The above mentioned companies are being profiled along with their key financials and strategies for growth.

By combining SPSS Inc.’s data integration and analysis capabilities with our relevant findings, we have predicted the future growth of the industry. We employed various significant variables that have an impact on this industry and created regression models with SPSS Base to determine the future direction of the industry. Before deploying the regression model, the relationship between several independent or predictor variables and the dependent variable was analyzed using standard SPSS output, including charts, tables and tests.
More ....

To Enquire Regarding This Report@ http://www.researchmoz.us/enquiry.php?type=E&repid=242777

About ResearchMoz
ResearchMoz is the world’s fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz’s service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.

Blog: http://dynamicmarketresearch.blogspot.com/

Global Hemodialysis Consumption Industry 2016 Market Research Report

The Global Hemodialysis Consumption 2016 Market Research Report is a professional and in-depth study on the current state of the Hemodialysis market.

First, the report provides a basic overview of the Hemodialysis industry including definitions, classifications, applications and industry chain structure. And development policies and plans are discussed as well as manufacturing processes and cost structures.

To Download Sample Report With TOC@ http://www.researchmoz.us/enquiry.php?type=S&repid=590932

Secondly, the report states the global Hemodialysis market size (volume and value), and the segment markets by regions, types, applications and companies are also discussed.

Third, the Hemodialysis market analysis is provided for major regions including USA, Europe, China and Japan, and other regions can be added. For each region, market size and end users are analyzed as well as segment markets by types, applications and companies.

Then, the report focuses on global major leading industry players with information such as company profiles, product picture and specifications, sales, market share and contact information. What’s more, the Hemodialysis industry development trends and marketing channels are analyzed.

Finally, the feasibility of new investment projects is assessed, and overall research conclusions are offered.

In a word, the report provides major statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

Table of Contents

1 Industry Overview of Hemodialysis1.1 Definition and Specifications of Hemodialysis
1.1.1 Definition of Hemodialysis
1.1.2 Specifications of Hemodialysis
1.2 Classification of Hemodialysis
1.3 Applications of Hemodialysis
1.4 Industry Chain Structure of Hemodialysis
1.5 Industry Overview and Major Regions Status of Hemodialysis
1.5.1 Industry Overview of Hemodialysis
1.5.2 Global Major Regions Status of Hemodialysis
1.6 Industry Policy Analysis of Hemodialysis
1.7 Industry News Analysis of Hemodialysis

2 Manufacturing Cost Structure Analysis of Hemodialysis2.1 Raw Material Suppliers and Price Analysis of Hemodialysis
2.2 Equipment Suppliers and Price Analysis of Hemodialysis
2.3 Labor Cost Analysis of Hemodialysis
2.4 Other Costs Analysis of Hemodialysis
2.5 Manufacturing Cost Structure Analysis of Hemodialysis
2.6 Manufacturing Process Analysis of Hemodialysis
More ....

To Enquire Regarding This Report@ http://www.researchmoz.us/enquiry.php?type=E&repid=590932

About ResearchMoz

ResearchMoz is the world’s fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz’s service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.

Blog: http://dynamicmarketresearch.blogspot.com/

Supraventricular Tachycardia (SVT) Therapeutics - Pipeline Assessment and Market Forecasts to 2019

Industry analysis specialist, has released its new report, Supraventricular Tachycardia (SVT) Therapeutics - Pipeline Assessment and Market Forecasts to 2019. The report is an essential source of information and analysis on the global Supraventricular Tachycardia (SVT) Therapeutics market. The report identifies the key trends shaping and driving the global Supraventricular Tachycardia (SVT) Therapeutics market. The report also provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders. Most importantly, the report provides valuable insights on the pipeline products within the global Supraventricular Tachycardia (SVT) Therapeutics sector. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalDatas team of industry experts.

To Download Sample Report With TOC@ http://www.researchmoz.us/enquiry.php?type=S&repid=131526

Scope

The report provides information on the key drivers and challenges of the Supraventricular Tachycardia (SVT) Therapeutics market. Its scope includes -
Annualized seven key markets (US, France, Germany, Italy, Spain, UK and Japan) Supraventricular Tachycardia (SVT) Therapeutics market revenues data from 2006 to 2011, forecast for eight years to 2019.
Pipeline analysis data providing a split across the different phases, mechanisms of action being developed and emerging trends by seven key markets. Pipeline candidates fall under major therapeutic classes.
Analysis of the current and future competition in the seven key countries Supraventricular Tachycardia (SVT) Therapeutics market.
Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications.
Key topics covered include strategic competitor assessment, market characterization, unmet needs and the implications for the Supraventricular Tachycardia (SVT) Therapeutics market.
Analysis of key recent licensing and partnership agreements in Supraventricular Tachycardia (SVT) Therapeutics market

Reasons to buy

The report will enhance your decision making capability. It will allow you to -
Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies and by identifying the companies with the most robust pipeline.
Develop business strategies by understanding the trends shaping and driving the global Supraventricular Tachycardia (SVT) Therapeutics market.
Drive revenues by understanding the key trends, innovative products and technologies, market segments and companies likely to impact the global Supraventricular Tachycardia (SVT) Therapeutics market in future.
Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
Whats the next big thing in the global Supraventricular Tachycardia (SVT) Therapeutics market landscape? Identify, understand and capitalize.

More ....

To Enquire Regarding This Report@ http://www.researchmoz.us/enquiry.php?type=E&repid=131526

About ResearchMoz

ResearchMoz is the world’s fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz’s service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.

Blog: http://dynamicmarketresearch.blogspot.com/